Presentation of the Centre
The KHCC is an independent, non-governmental, non-profit institution founded in 1997 by a Royal Decree to fight cancer in
Jordan and the Middle East Region. As an internationally-accredited comprehensive cancer care & research centre,
it provides adult and paediatric patients with more advanced care for all types of tumours.
KHCC with more than 3,000 employees, and treating over 65% of cancer cases in Jordan, is considered the largest oncology service provider.
Main Research Activities
Research at KHCC has made significant strides in the last few years both in terms of quantity and quality. In 2023, 181 research applications were submitted by KHCC researchers. There are currently 32 ongoing clinical trials addressing patients with grim prognoses and incorporating novel biomarker-driven treatments that may not be available outside the research setting. In 2023, 22.6 % of new patients were enrolled in interventional prospective clinical studies (drug-based and other). 243 scientific publications, including book chapters, reviews, case reports and research papers were published in 2023. Through dedicated efforts with key stakeholders at national, regional and international levels, coupled with strategic institutional directions, these achievements will continue to grow.
Core Facilities
The KHCC campus has a 352 bed capacity. It is staffed and equipped to provide a comprehensive range of oncology services from traditional chemotherapy to cutting-edge intra-operative MRI-guided neurosurgery. The KHCC provides advanced radiotherapy, surgery, and bone marrow transplant services.
Education
KHCC offers accredited academic oncology programmes and training opportunities to students, residents, and fellows. Through partnering with the University of Jordan, KHCC uniquely offers a Master’s degree in Cancer Care Informatics and 9 diploma programmes. These include pain management, oncology nursing, palliative & supportive care and tobacco control.